Trial Profile
Comparison of tirofiban combined with dalteparin or unfractionated heparin in primary percutaneous coronary intervention of acute ST-segment elevation myocardial infarction patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Dec 2011
Price :
$35
*
At a glance
- Drugs Dalteparin sodium (Primary) ; Heparin (Primary) ; Tirofiban (Primary)
- Indications Embolism and thrombosis; Myocardial infarction
- Focus Therapeutic Use
- 21 Dec 2011 New trial record